Trials / Completed
CompletedNCT02750943
Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease
A Clinical Study Investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 253 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This will be a single-center, 12 week, examiner-blind, randomized, stratified (gender and baseline mean whole mouth MGI score), two-treatment, parallel group, clinical study in healthy adult volunteers with moderate gingivitis. This study will evaluate the efficacy of a dentifrice containing 0.454% weight by weight (w/w) stannous fluoride to control gingivitis and gingival bleeding following 12 weeks twice daily brushing, compared to a negative control dentifrice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stannous Fluoride | Dentifrice containing 0.454% w/w stannous fluoride |
| DRUG | Sodium Monofluorophosphate | Dentifrice containing 1000ppm fluoride as sodium monofluorophosphate |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-04
- First posted
- 2016-04-26
- Last updated
- 2017-10-26
- Results posted
- 2016-11-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02750943. Inclusion in this directory is not an endorsement.